|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/47 | (2006.01) |
| C07K 14/82 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3377516 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16867262.4 |
| Date of filing the European patent application | 2016-11-18 | |
| (97) | Date of publication of the European application | 2018-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-15 |
| (46) | Date of publication of the claims translation | 2022-09-26 |
| (86) | Number | PCT/US2016/062865 |
| Date | 2016-11-18 |
| (87) | Number | WO 2017/087857 |
| Date | 2017-05-26 |
| (30) | Number | Date | Country code |
| 201562258134 P | 2015-11-20 | US |
| (72) |
SCHEINBERG, David A. , US
|
| (73) |
Memorial Sloan Kettering Cancer Center ,
Office of Industrial Affairs
1275 York Avenue, New York, NY 10065,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicija vėžiui gydyti |
| COMPOSITION FOR TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-10-21 | 10 | 231.00 EUR |
| 2026-11-18 |